These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11733404)

  • 1. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging.
    Oshinski JN; Yang Z; Jones JR; Mata JF; French BA
    Circulation; 2001 Dec; 104(23):2838-42. PubMed ID: 11733404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.
    Watzinger N; Lund GK; Higgins CB; Wendland MF; Weinmann HJ; Saeed M
    J Magn Reson Imaging; 2002 Dec; 16(6):633-40. PubMed ID: 12451576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
    Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping.
    Kirschner R; Varga-Szemes A; Brott BC; Litovsky S; Elgavish A; Elgavish GA; Simor T
    Magn Reson Imaging; 2011 Jun; 29(5):650-8. PubMed ID: 21546192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.
    Kim RJ; Chen EL; Lima JA; Judd RM
    Circulation; 1996 Dec; 94(12):3318-26. PubMed ID: 8989146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media.
    Saeed M; Lund G; Wendland MF; Bremerich J; Weinmann H; Higgins CB
    Circulation; 2001 Feb; 103(6):871-6. PubMed ID: 11171797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of reperfused myocardial infarction in the hyper-acute phase with delayed enhancement magnetic resonance imaging.
    Zhu X; Zhang R; Campagna NF; Zhao M
    J Cardiovasc Magn Reson; 2006; 8(3):461-7. PubMed ID: 16755832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents.
    Schwitter J; Saeed M; Wendland MF; Derugin N; Canet E; Brasch RC; Higgins CB
    J Am Coll Cardiol; 1997 Oct; 30(4):1086-94. PubMed ID: 9316544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occlusive and reperfused myocardial infarcts: MR imaging differentiation with nonionic Gd-DTPA-BMA.
    Masui T; Saeed M; Wendland MF; Higgins CB
    Radiology; 1991 Oct; 181(1):77-83. PubMed ID: 1887058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR.
    Kirschner R; Toth L; Varga-Szemes A; Simor T; Suranyi P; Kiss P; Ruzsics B; Toth A; Baker R; Brott BC; Litovsky S; Elgavish A; Elgavish GA
    J Cardiovasc Magn Reson; 2010 Apr; 12(1):22. PubMed ID: 20377842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging.
    Petersen SE; Mohrs OK; Horstick G; Oberholzer K; Abegunewardene N; Ruetzel K; Selvanayagam JB; Robson MD; Neubauer S; Thelen M; Meyer J; Kreitner KF
    J Cardiovasc Magn Reson; 2004; 6(2):541-8. PubMed ID: 15137338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of experimental myocardial infarction.
    Wikström M
    Acta Radiol Suppl; 1992; 379():1-30. PubMed ID: 1317989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of reperfused myocardial infarction by Gd-DOTA-enhanced magnetic resonance imaging. An experimental study.
    Ovize M; Revel D; de Lorgeril M; Pichard JB; Dandis G; Delaye J; Renaud S; Amiel M
    Invest Radiol; 1991 Dec; 26(12):1065-70. PubMed ID: 1765439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats.
    Knight RA; Barker PB; Fagan SC; Li Y; Jacobs MA; Welch KM
    Stroke; 1998 Jan; 29(1):144-51. PubMed ID: 9445344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction.
    Baks T; Cademartiri F; Moelker AD; Weustink AC; van Geuns RJ; Mollet NR; Krestin GP; Duncker DJ; de Feyter PJ
    J Am Coll Cardiol; 2006 Jul; 48(1):144-52. PubMed ID: 16814660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA--enhanced MR imaging.
    de Roos A; van Rossum AC; van der Wall E; Postema S; Doornbos J; Matheijssen N; van Dijkman PR; Visser FC; van Voorthuisen AE
    Radiology; 1989 Sep; 172(3):717-20. PubMed ID: 2772179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.
    Ruzsics B; Surányi P; Kiss P; Brott BC; Elgavish A; Simor T; Elgavish GA
    J Magn Reson Imaging; 2008 Dec; 28(6):1386-92. PubMed ID: 19025946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction.
    Yang Z; Berr SS; Gilson WD; Toufektsian MC; French BA
    Circulation; 2004 Mar; 109(9):1161-7. PubMed ID: 14967719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial infarction and postinfarction scar remodeling with an elastin-specific magnetic resonance agent.
    Wildgruber M; Bielicki I; Aichler M; Kosanke K; Feuchtinger A; Settles M; Onthank DC; Cesati RR; Robinson SP; Huber AM; Rummeny EJ; Walch AK; Botnar RM
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):321-9. PubMed ID: 24363356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis.
    Van Rossum AC; Visser FC; Van Eenige MJ; Sprenger M; Valk J; Verheugt FW; Roos JP
    Am J Cardiol; 1990 Apr; 65(13):845-51. PubMed ID: 2321534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.